Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis |
Scleroderma, Diffuse | Phase2 | Australia Austria Brazil Czechia Denmark France Germany Hungary Israel Italy Japan Netherlands Singapore South Korea Spain Switzerland Taiwan United States View all |
NCT06655896 |
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy |
Prostate Cancer | Phase2, Phase3 | Australia Brazil China Hong Kong Israel Japan Singapore South Korea Switzerland Taiwan United States View all |
NCT06780670 |
Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. |
Ankylosing Spondylitis | South Korea | NCT06905288 | |
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma |
Asthma | Phase3 | Argentina Austria Bulgaria Colombia Czechia Greece Guatemala Hungary Italy Mexico Panama Portugal Romania South Africa Spain Vietnam View all |
NCT05562466 |
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria |
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) | Phase2 | France Germany Poland Spain United States View all |
NCT06865651 |
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. |
C3G | Phase3 | Brazil Canada China Germany United States View all |
NCT04817618 |
DFT383 in Pediatric Participants With Nephropathic Cystinosis |
Nephropathic Cystinosis | Phase1, Phase2 | United States | NCT06910813 |
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients |
Hypertension | Phase2 | Japan Singapore United States |
NCT06857955 |
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis |
Lupus Nephritis | Phase3 | Argentina Brazil Canada Colombia Estonia France Germany Guatemala Hong Kong Hungary India Italy Lithuania Malaysia Mexico Romania Singapore South Korea Spain Taiwan Thailand United Kingdom United States View all |
NCT05126277 |
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. |
Generalized Myasthenia Gravis | Phase3 | Argentina Brazil China Denmark France Germany Greece Israel Italy Japan Poland Portugal Serbia South Korea Spain United Kingdom United States View all |
NCT06517758 |